Welcome to the Brain & Behavior Lab Monthly Newsletter Vol. 1, Issue 4, August 2024 |
|
|
Dr. Modestino's Director's Blog August 2024: A Month in Review of Neuroscience News Articles Referring to Original Research | | |
|
|
We are pleased to announce that Dr. Modestino has just received his license as a mental health counselor (LMHC) in the state of Rhode Island! Please congratulate him! |
|
|
Breaking news!Our Case Study Publication about RSD has just been published with Dr. Dodson! Rejection Sensitivity Dysphoria in Attention-Deficit/Hyperactivity Disorder: A Case Series. | | |
|
|
Research Assistant Brian DeMille has reviewed this RSD Case Series publication. | | |
|
|
Dr. Dodson has an upcoming book titled Treating ADHD. You can get updates from Dr. Dodson's website. |
|
|
Ny'Asia Green Dr. Modestino's student, Ny'Asia Green, has joined the lab as a research intern for the fall 2024 semester! | | |
|
|
Our Current Research:We have two survey studies: one about Rejection Sensitivity Dysphoria (RSD) in ADHD and another about the triggers of attacks in those with migraines and narcolepsy. We are looking for volunteers for our research! Click the link below! | | |
|
|
Rejection Sensitivity Dysphoria (RSD) in ADHD: Survey Study |
|
|
Triggers of hemiplegic attacks in those with hemiplegic migraines as well as catapletic attacks of those with narcolepsy: Survey Study |
|
|
Here is a list of our recent publications: Dodson, W.W., Modestino, E.J., Titiz-Ceritoğlu, H., & Zayed, B. (2024) Rejection Sensitivity Dysphoria in Attention-Deficit/Hyperactivity Disorder: A Case Series. Acta Scientific Neurology, 7(8): 23-30. DOI: 10.31080/ASNE.2024.07.0762 Zeine F, Jafari N, Baron D, Bowirrat A, Pinhasov A, et al. (2024). Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration. Therapy J Addict Psychiatry 8(1): 50-96. (Drs. Blum, Modestino, and Thanos are co-authors)
Modestino, E.J., Bowirrat A, Baron, D., Thanos, P.K., Hanna, C., Bagchi, D., Braverman, E.R., Dennen, C.A., Badgaiyan, R.D., Pollack, A.R., Lewandrowski, K.-U., Sharafshah, A., Gold, M.S., & Blum, K. (2024) Is there a natural, non-addictive, and non-anti-reward, safe, gene-based solution to treat Reward Deficiency Syndrome (RDS)? KB220 variants vs. GLP-1 analogs. J Addict Psychiatry, 8(1): 34-49
Modestino, E.J., Bowirrat, A., Lewandowski, K.-U., Sharafshah, A., Badgaiyan, R.D., Thanos, P.K., Baron, D., Dennen, C.A., Elman, I., Sunder, K., Murphy, K.T., & Blum, K. (2024). Hemiplegic migraines exacerbated using an injectable GLP-1 agonist for weight loss. Acta Scientific Neurology, 7(5): 12-18. DOI: 10.31080/ASNE.2024.07.0731
Dodson, W.W., & Modestino, E.J. (2024). Have we placed the cart before the horse by using alpha-2A agonists to treat rejection sensitivity dysphoria in ADHD? Current Psychopharmacology, e050424228696. DOI: 10.2174/0122115560297397240404071044 Blum, K., Bowirrat, A., Baron, D., Elman, I., Makale, M. T., Cadet, J. L., Thanos, P. K., Hanna, C., Ahmed, R., Gondre-Lewis, M. C., Dennen, C. A., Braverman, E. R., Soni, D., Carney, P., Khalsa, J., Modestino, E. J., Barh, D., Bagchi, D., Badgaiyan, R. D., … Gold, M. S. (2024). Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences. Gene & Protein in Disease, 3(1), 1966. https://doi.org/10.36922/gpd.1966
|
|
|
We have added a new section to our website to provide informational brochures. We will be adding to this over the fall semester. | | |
|
|
Visit our lab shop for lab merch! | | |
|
|
Subscribe to our monthly newsletter |
|
|
|
|
